AbalovichM, AminoN, BarbourLA, CobinRH, De GrootLJ, GlinoerD, MandelSJ, Stagnaro-GreenA. 2007. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 92,8 Suppl:S1–47.
2.
GharibH, CobinRH, DickeyRA. 1999. Subclinical hypothyroidism during pregnancy: position statement from the American Association of Clinical Endocrinologists. Endocr Pract, 5:367–368.
3.
U.S., Preventive Services Task Force Ratings: Strength of Recommendations and Quality of Evidence. 2003. Guide to Clinical Preventive Services, Third Edition: Period Updates, 2000–2003. www.uspreventiveservicestaskforce.org/3rduspstf/ratings.htm. 2011 June 13.
4.
van RaaijJM, Vermaat-MiedemaSH, SchonkCM, PeekME, HautvastJG. 1987. Energy requirements of pregnancy in The Netherlands. Lancet, 2:953–955.
5.
GlinoerD. 1997. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev, 18:404–433.
6.
BalochZ, CarayonP, Conte-DevolxB, DemersLM, Feldt-RasmussenU, HenryJF, LiVosliVA, Niccoli-SireP, JohnR, RufJ, SmythPP, SpencerCA, StockigtJR. Guidelines Committee, National Academy of Clinical Biochemistry. 2003. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 13:3–126.
7.
SoldinOP, TractenbergRE, HollowellJG, JonklaasJ, JanicicN, SoldinSJ. 2004. Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency. Thyroid, 14:1084–1090.
8.
NegroR. 2009. Significance and management of low TSH in pregnancy. LazarusJ, PiragsV, ButzS. The Thyroid and Reproduction. Georg Thieme Verlag: New York, 84–95.
9.
Kahric-JanicicN, SoldinSJ, SoldinOP, WestT, GuJ, JonklaasJ. 2007. Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid, 17:303–311.
10.
SoldinOP, Hilakivi-ClarkeL, WeiderpassE, SoldinSJ. 2004. Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays. Clin Chim Acta, 349:181–189.
11.
RotiE, GardiniE, MinelliR, BianconiL, FlisiM. 1991. Thyroid function evaluation by different commercially available free thyroid hormone measurement kits in term pregnant women and their newborns. J Endocrinol Invest, 14:1–9.
12.
SapinR, D'HerbomezM, SchliengerJL. 2004. Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy. Clin Lab, 50:581–584.
13.
HaddowJE, KnightGJ, PalomakiGE, McClainMR, PulkkinenAJ. 2004. The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen, 11:170–174.
14.
StrickerR, EchenardM, EberhartR, ChevaillerMC, PerezV, QuinnFA, StrickerR. 2007. Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol, 157:509–514.
15.
PanesarNS, LiCY, RogersMS. 2001. Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem, 38:329–332.
16.
SoldinOP, SoldinD, SastoqueM. 2007. Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide. Ther Drug Monit, 29:553–559.
17.
Bocos-TerrazJP, Izquierdo-AlvarezS, Bancalero-FloresJL, Alvarez-LahuertaR, Aznar-SaucaA, Real-LopezE, Ibanez-MarcoR, Bocanegra-GarciaV, Rivera-SanchezG. 2009. Thyroid hormones according to gestational age in pregnant Spanish women. BMC Res Notes, 2:237.
18.
MarwahaRK, ChopraS, GopalakrishnanS, SharmaB, KanwarRS, SastryA, SinghS. 2008. Establishment of reference range for thyroid hormones in normal pregnant Indian women. BJOG, 115:602–606.
19.
DasheJS, CaseyBM, WellsCE, McIntireDD, ByrdEW, LevenoKJ, CunninghamFG. 2005. Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol, 106:753–757.
20.
LockwoodCM, GrenacheDG, GronowskiAM. 2009. Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations. Thyroid, 19:863–868.
21.
PriceA, ObelO, CresswellJ, CatchI, RutterS, BarikS, HellerSR, WeetmanAP. 2001. Comparison of thyroid function in pregnant and non-pregnant Asian and western Caucasian women. Clin Chim Acta, 308:91–98.
22.
WalkerJA, IllionsEH, HuddlestonJF, SmallridgeRC. 2005. Racial comparisons of thyroid function and autoimmunity during pregnancy and the postpartum period. Obstet Gynecol, 106:1365–1371.
23.
BenhadiN, WiersingaWM, ReitsmaJB, VrijkotteTG, van der WalMF, BonselGJ. 2007. Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy. Clin Endocrinol (Oxf), 66:765–770.
24.
ThienpontLM, Van UytfangheK, BeastallG, FaixJD, IeiriT, MillerWG, NelsonJC, RoninC, RossHA, ThijssenJH, ToussaintB. IFCC Working Group on Standardization of Thyroid Function Tests. 2010. Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 1: thyroid-stimulating hormone. Clin Chem, 56:902–911.
ToftAD, BeckettGJ. 2005. Measuring serum thyrotropin, thyroid hormone, assessing thyroid hormone transport. BravermanLE, UtigerRD. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 9th. Lippincott, Williams & Wilkins: Philadelphia, 329–344.
27.
AnckaertE, PoppeK, Van UytfangheK, SchiettecatteJ, FoulonW, ThienpontLM. 2010. FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID-LC/tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations. Clin Chim Acta, 411:1348–1353.
28.
NegroR, FormosoG, MangieriT, PezzarossaA, DazziD, HassanH. 2006. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab, 91:2587–2591.
29.
SapinR, d'HerbomezM. 2003. Free thyroxine measured by equilibrium dialysis and nine immunoassays in sera with various serum thyroxine-binding capacities. Clin Chem, 49:1531–1535.
30.
LeeRH, SpencerCA, MestmanJH, MillerEA, PetrovicI, BravermanLE, GoodwinTM. 2009. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol, 200:260.e1–260.e6.
31.
StockigtJ. 2003. Assessment of thyroid function: towards an integrated laboratory—clinical approach. Clin Biochem Rev, 24:109–122.
32.
YueB, RockwoodAL, SandrockT, La'uluSL, KushnirMM, MeikleAW. 2008. Free thyroid hormones in serum by direct equilibrium dialysis and online solid-phase extraction—liquid chromatography/tandem mass spectrometry. Clin Chem, 54:642–651.
33.
JonklaasJ, Kahric-JanicicN, SoldinOP, SoldinSJ. 2009. Correlations of free thyroid hormones measured by tandem mass spectrometry and immunoassay with thyroid-stimulating hormone across 4 patient populations. Clin Chem, 55:1380–1388.
34.
ThienpontLM, Van UytfangheK, BeastallG, FaixJD, IeiriT, MillerWG, NelsonJC, RoninC, RossHA, ThijssenJH, ToussaintB. IFCC Working Group on Standardization of Thyroid Function Tests. 2010. Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 2: free thyroxine and free triiodothyronine. Clin Chem, 56:912–920.
AllanWC, HaddowJE, PalomakiGE, WilliamsJR, MitchellML, HermosRJ, FaixJD, KleinRZ. 2000. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen, 7:127–130.
37.
HaddowJE, PalomakiGE, AllanWC, WilliamsJR, KnightGJ, GagnonJ, O'HeirCE, MitchellML, HermosRJ, WaisbrenSE, FaixJD, KleinRZ. 1999. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med, 341:549–555.
NegroR, SchwartzA, GismondiR, TinelliA, MangieriT, Stagnaro-GreenA. 2010. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab, 95:1699–1707.
41.
NegroR, SchwartzA, GismondiR, TinelliA, MangieriT, Stagnaro-GreenA. 2010. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab, 95:E44–8.
42.
BenhadiN, WiersingaWM, ReitsmaJB, VrijkotteTG, BonselGJ. 2009. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol, 160:985–991.
MannistoT, VaarasmakiM, PoutaA, HartikainenAL, RuokonenA, SurcelHM, BloiguA, JarvelinMR, Suvanto-LuukkonenE. 2009. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab, 94:772–779.
45.
MannistoT, VaarasmakiM, PoutaA, HartikainenAL, RuokonenA, SurcelHM, BloiguA, JarvelinMR, SuvantoE. 2010. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab, 95:1084–1094.
46.
AshoorG, MaizN, RotasM, JawdatF, NicolaidesKH. 2010. Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death. Thyroid, 20:989–993.
47.
ManEB, BrownJF, SerunianSA. 1991. Maternal hypothyroxinemia: psychoneurological deficits of progeny. Ann Clin Lab Sci, 21:227–239.
48.
ManEB, JonesWS, HoldenRH, MellitsED. 1971. Thyroid function in human pregnancy. 8. Retardation of progeny aged 7 years; relationships to maternal age and maternal thyroid function. Am J Obstet Gynecol, 111:905–916.
49.
de EscobarGM, ObregonMJ, del ReyFE. 2004. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab, 18:225–248.
50.
PopVJ, BrouwersEP, VaderHL, VulsmaT, van BaarAL, de VijlderJJ. 2003. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf), 59:282–288.
51.
LiY, ShanZ, TengW, YuX, LiY, FanC, TengX, GuoR, WangH, LiJ, ChenY, WangW, ChawingaM, ZhangL, YangL, ZhaoY, HuaT. 2010. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25–30 months. Clin Endocrinol (Oxf), 72:825–829.
52.
HenrichsJ, Bongers-SchokkingJJ, SchenkJJ, GhassabianA, SchmidtHG, VisserTJ, HooijkaasH, de Muinck Keizer-SchramaSM, HofmanA, JaddoeVV, VisserW, SteegersEA, VerhulstFC, de RijkeYB, TiemeierH. 2010. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the Generation R Study. J Clin Endocrinol Metab, 95:4227–4234.
53.
MandelSJ, LarsenPR, SeelyEW, BrentGA. 1990. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med, 323:91–96.
54.
AlexanderEK, MarquseeE, LawrenceJ, JarolimP, FischerGA, LarsenPR. 2004. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med, 351:241–249.
55.
KaplanMM. 1992. Monitoring thyroxine treatment during pregnancy. Thyroid, 2:147–152.
56.
LohJA, WartofskyL, JonklaasJ, BurmanKD. 2009. The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid, 19:269–275.
57.
YassaL, MarquseeE, FawcettR, AlexanderEK. 2010. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab, 95:3234–3241.
58.
AbalovichM, AlcarazG, Kleiman-RubinszteinJ, PavloveMM, CornelioC, LevalleO, GutierrezS. 2010. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid, 20:1175–1178.
DuntasLH, MantzouE, KoutrasDA. 2003. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol, 148:389–393.
63.
MazokopakisEE, PapadakisJA, PapadomanolakiMG, BatistakisAG, GiannakopoulosTG, ProtopapadakisEE, GanotakisES. 2007. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis. Thyroid, 17:609–612.
64.
KaranikasG, SchuetzM, KonturS, DuanH, KommataS, SchoenR, AntoniA, KletterK, DudczakR, WillheimM. 2008. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid, 18:7–12.
65.
NegroR, GrecoG, MangieriT, PezzarossaA, DazziD, HassanH. 2007. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab, 92:1263–1268.
66.
StrangesS, MarshallJR, NatarajanR, DonahueRP, TrevisanM, CombsGF, CappuccioFP, CerielloA, ReidME. 2007. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med, 147:217–223.
67.
BravermanLE, UtigerRD. 2005. Introduction to thyrotoxicosis. BravermanLE, UtigerRD. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 9th. Lippincott, Williams and Wilkins: Philadelphia, 453–455.
68.
Patil-SisodiaK, MestmanJH. 2010. Graves hyperthyroidism and pregnancy: a clinical update. Endocr Pract, 16:118–129.
69.
KrassasGE, PoppeK, GlinoerD. 2010. Thyroid function and human reproductive health. Endocr Rev, 31:702–755.
70.
GoodwinTM, MontoroM, MestmanJH. 1992. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol, 167:648–652.
NiebylJR. 2010. Clinical practice. Nausea and vomiting in pregnancy. N Engl J Med, 363:1544–1550.
73.
VerbergMF, GillottDJ, Al-FardanN, GrudzinskasJG. 2005. Hyperemesis gravidarum, a literature review. Hum Reprod Update, 11:527–539.
74.
HershmanJM. 1999. Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors. Thyroid, 9:653–657.
75.
GrunJP, MeurisS, De NayerP, GlinoerD. 1997. The thyrotrophic role of human chorionic gonadotrophin (hCG) in the early stages of twin (versus single) pregnancies. Clin Endocrinol (Oxf), 46:719–725.
76.
RodienP, BremontC, SansonML, ParmaJ, Van SandeJ, CostagliolaS, LutonJP, VassartG, DuprezL. 1998. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med, 339:1823–1826.
77.
GlinoerD, SpencerCA. 2010. Serum TSH determinations in pregnancy: how, when and why?Nat Rev Endocrinol, 6:526–529.
78.
BouillonR, NaesensM, Van AsscheFA, De KeyserL, De MoorP, RenaerM, De VosP, De RooM. 1982. Thyroid function in patients with hyperemesis gravidarum. Am J Obstet Gynecol, 143:922–926.
79.
LaurbergP, BournaudC, KarmisholtJ, OrgiazziJ. 2009. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol, 160:1–8.
MillarLK, WingDA, LeungAS, KooningsPP, MontoroMN, MestmanJH. 1994. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol, 84:946–949.
82.
PapendieckP, ChiesaA, PrietoL, Gruneiro-PapendieckL. 2009. Thyroid disorders of neonates born to mothers with Graves' disease. J Pediatr Endocrinol Metab, 22:547–553.
83.
PhoojaroenchanachaiM, SriussadapornS, PeerapatditT, VannasaengS, NitiyanantW, BoonnamsiriV, VichayanratA. 2001. Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol (Oxf), 54:365–370.
84.
SheffieldJS, CunninghamFG. 2004. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol, 190:211–217.
85.
MandelSJ, CooperDS. 2001. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab, 86:2354–2359.
86.
AziziF. 2006. The safety and efficacy of antithyroid drugs. Expert Opin Drug Saf, 5:107–116.
87.
ClementiM, Di GianantonioE, PeloE, MammiI, BasileRT, TenconiR. 1999. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet, 83:43–46.
88.
BarberoP, ValdezR, RodriguezH, TiscorniaC, MansillaE, AllonsA, CollS, LiascovichR. 2008. Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A, 146A:2390–2395.
89.
ClementiM, Di GianantonioE, CassinaM, LeonciniE, BottoLD, MastroiacovoP. SAFE-Med Study Group. 2010. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab, 95:E337–41.
90.
RivkeesSA, MattisonDR. 2009. Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol, 2009:132041.
91.
RussoMW, GalankoJA, ShresthaR, FriedMW, WatkinsP. 2004. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl, 10:1018–1023.
92.
BahnRS, BurchHS, CooperDS, GarberJR, GreenleeCM, KleinIL, LaurbergP, McDougallIR, RivkeesSA, RossD, SosaJA, StanMN. 2009. The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid, 19:673–674.
93.
RubinPC. 1981. Current concepts: beta-blockers in pregnancy. N Engl J Med, 305:1323–1326.
94.
SherifIH, OyanWT, BosairiS, CarrascalSM. 1991. Treatment of hyperthyroidism in pregnancy. Acta Obstet Gynecol Scand, 70:461–463.
GlinoerD. 1998. Thyroid hyperfunction during pregnancy. Thyroid, 8:859–864.
97.
MomotaniN, NohJ, OyanagiH, IshikawaN, ItoK. 1986. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med, 315:24–28.
98.
Ochoa-MayaMR, FratesMC, Lee-ParritzA, SeelyEW. 1999. Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism. Thyroid, 9:1111–1114.
99.
HamburgerJI. 1992. Diagnosis and management of Graves' disease in pregnancy. Thyroid, 2:219–224.
100.
AminoN, TanizawaO, MoriH, IwataniY, YamadaT, KurachiK, KumaharaY, MiyaiK. 1982. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab, 55:108–112.
101.
LaurbergP, NygaardB, GlinoerD, GrussendorfM, OrgiazziJ. 1998. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol, 139:584–586.
102.
MomotaniN, HisaokaT, NohJ, IshikawaN, ItoK. 1992. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. J Clin Endocrinol Metab, 75:738–744.
103.
KempersMJ, van TijnDA, van TrotsenburgAS, de VijlderJJ, WiedijkBM, VulsmaT. 2003. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab, 88:5851–5857.
104.
Zwaveling-SoonawalaN, van TrotsenburgP, VulsmaT. 2009. Central hypothyroidism in an infant born to an adequately treated mother with Graves' disease: an effect of maternally derived thyrotrophin receptor antibodies?Thyroid, 19:661–662.
105.
GrunerC, KollertA, WildtL, DorrHG, BeinderE, LangN. 2001. Intrauterine treatment of fetal goitrous hypothyroidism controlled by determination of thyroid-stimulating hormone in fetal serum. A case report and review of the literature. Fetal Diagn Ther, 16:47–51.
106.
LutonD, Le GacI, VuillardE, CastanetM, GuibourdencheJ, NoelM, ToubertME, LegerJ, BoissinotC, SchlageterMH, GarelC, TebekaB, OuryJF, CzernichowP, PolakM. 2005. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab, 90:6093–6098.
107.
McKenzieJM, ZakarijaM. 1992. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid, 2:155–159.
108.
MitsudaN, TamakiH, AminoN, HosonoT, MiyaiK, TanizawaO. 1992. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol, 80:359–364.
109.
PelegD, CadaS, PelegA, Ben-AmiM. 2002. The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol, 99:1040–1043.
110.
ZimmermanD. 1999. Fetal and neonatal hyperthyroidism. Thyroid, 9:727–733.
111.
PolakM, Le GacI, VuillardE, GuibourdencheJ, LegerJ, ToubertME, MadecAM, OuryJF, CzernichowP, LutonD. 2004. Fetal and neonatal thyroid function in relation to maternal Graves' disease. Best Pract Res Clin Endocrinol Metab, 18:289–302.
112.
CohenO, Pinhas-HamielO, SivanE, DolitskiM, LipitzS, AchironR. 2003. Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy. Prenat Diagn, 23:740–742.
113.
HuelC, GuibourdencheJ, VuillardE, OuahbaJ, PikettyM, OuryJF, LutonD. 2009. Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter. Ultrasound Obstet Gynecol, 33:412–420.
114.
PorrecoRP, BlochCA. 1990. Fetal blood sampling in the management of intrauterine thyrotoxicosis. Obstet Gynecol, 76:509–512.
115.
DaffosF, Capella-PavlovskyM, ForestierF. 1985. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol, 153:655–660.
116.
NachumZ, RakoverY, WeinerE, ShalevE. 2003. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol, 189:159–165.
117.
KilpatrickS. 2003. Umbilical blood sampling in women with thyroid disease in pregnancy: is it necessary?Am J Obstet Gynecol, 189:1–2.
118.
Stagnaro-GreenA. 2004. Postpartum thyroiditis. Best Pract Res Clin Endocrinol Metab, 18:303–316.
119.
AziziF. 2006. Treatment of post-partum thyrotoxicosis. J Endocrinol Invest, 29:244–247.
120.
RotondiM, CappelliC, PiraliB, PirolaI, MagriF, FonteR, CastellanoM, RoseiEA, ChiovatoL. 2008. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab, 93:3985–3988.
121.
Benhaim RochesterD, DaviesTF. 2005. Increased risk of Graves' disease after pregnancy. Thyroid, 15:1287–1290.
122.
RotondiM, PiraliB, LodigianiS, BrayS, LeporatiP, ChytirisS, BalzanoS, MagriF, ChiovatoL. 2008. The post partum period and the onset of Graves' disease: an overestimated risk factor. Eur J Endocrinol, 159:161–165.
123.
AziziF, HedayatiM. 2002. Thyroid function in breast-fed infants whose mothers take high doses of methimazole. J Endocrinol Invest, 25:493–496.
124.
AziziF, BahrainianM, KhamsehME, KhoshniatM. 2003. Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Pediatr Endocrinol Metab, 16:1239–1243.
125.
GlinoerD. 2007. The importance of iodine nutrition during pregnancy. Public Health Nutr, 10:1542–1546.
126.
LibermanCS, PinoSC, FangSL, BravermanLE, EmersonCH. 1998. Circulating iodide concentrations during and after pregnancy. J Clin Endocrinol Metab, 83:3545–3549.
127.
BranderL, AlsC, BuessH, HaldimannF, HarderM, HanggiW, HerrmannU, LauberK, NiedererU, ZurcherT, BurgiU, GerberH. 2003. Urinary iodine concentration during pregnancy in an area of unstable dietary iodine intake in Switzerland. J Endocrinol Invest, 26:389–396.
128.
AziziF, SmythP. 2009. Breastfeeding and maternal and infant iodine nutrition. Clin Endocrinol (Oxf), 70:803–809.
129.
AndersenS, KarmisholtJ, PedersenKM, LaurbergP. 2008. Reliability of studies of iodine intake and recommendations for number of samples in groups and in individuals. Br J Nutr, 99:813–818.
130.
BerghoutA, WiersingaW. 1998. Thyroid size and thyroid function during pregnancy: an analysis. Eur J Endocrinol, 138:536–542.
131.
DelangeFM, DunnJT. 2005. Iodine deficiency. BravermanLE, UtigerRD. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 9th. Lippincott, Williams and Wilkins: Philadelphia, 264–288.
132.
World Health Organization/International Council for the Control of the Iodine Deficiency Disorders/United Nations Children's Fund (WHO/ICCIDD/UNICEF). 2007. Assessment of the iodine deficiency disorders and monitoring their elimination. World Health Organization: Geneva.
133.
VermiglioF, Lo PrestiVP, CastagnaMG, VioliMA, MoletiM, FinocchiaroMD, MattinaF, ArtemisiaA, TrimarchiF. 1999. Increased risk of maternal thyroid failure with pregnancy progression in an iodine deficient area with major iodine deficiency disorders. Thyroid, 9:19–24.
134.
de EscobarGM, ObregonMJ, del ReyFE. 2007. Iodine deficiency and brain development in the first half of pregnancy. Public Health Nutr, 10:1554–1570.
135.
CosteiraMJ, OliveiraP, SantosNC, AresS, Saenz-RicoB, Morreale de EscobarG, PalhaJA. 2011. Psychomotor development of children from an iodine-deficient region. J Pediatr, 159:447–453.
136.
International Council for Control of Iodine Deficiency Disorders. www.iccidd.org
137.
VermiglioF, Lo PrestiVP, MoletiM, SidotiM, TortorellaG, ScaffidiG, CastagnaMG, MattinaF, VioliMA, CrisaA, ArtemisiaA, TrimarchiF. 2004. Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries. J Clin Endocrinol Metab, 89:6054–6060.
138.
SoldinOP, SoldinSJ, PezzulloJC. 2003. Urinary iodine percentile ranges in the United States. Clin Chim Acta, 328:185–190.
139.
CaldwellKL, JonesR, HollowellJG. 2005. Urinary iodine concentration: United States National Health And Nutrition Examination Survey 2001–2002. Thyroid, 15:692–699.
140.
CaldwellKL, MakhmudovAA, ElyEK, JarrettJM, HenahanD, JonesRL. 2009. Iodine status of the U.S. population, NHANES 2005–2006. Thyroid, 19:S26–S27.
141.
CaldwellKL, MillerGA, WangRY, JainRB, JonesRL. 2008. Iodine status of the U.S. population, National Health and Nutrition Examination Survey 2003–2004. Thyroid, 18:1207–1214.
142.
HollowellJG, StaehlingNW, HannonWH, FlandersDW, GunterEW, MaberlyGF, BravermanLE, PinoS, MillerDT, GarbePL, DeLozierDM, JacksonRJ. 1998. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971–1974 and 1988–1994)J Clin Endocrinol Metab, 83:3401–3408.
143.
PerrineCG, HerrickK, SerdulaMK, SullivanKM. 2010. Some subgroups of reproductive age women in the United States may be at risk for iodine deficiency. J Nutr, 140:1489–1494.
144.
PearceEN, LeungAM, BlountBC, BazrafshanHR, HeX, PinoS, Valentin-BlasiniL, BravermanLE. 2007. Breast milk iodine and perchlorate concentrations in lactating Boston-area women. J Clin Endocrinol Metab, 92:1673–1677.
145.
KirkAB, MartinelangoPK, TianK, DuttaA, SmithEE, DasguptaPK. 2005. Perchlorate and iodide in dairy and breast milk. Environ Sci Technol, 39:2011–2017.
PharoahPO, ButtfieldIH, HetzelBS. 1971. Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet, 1:308–310.
148.
O'DonnellKJ, RakemanMA, Zhi-HongD, Xue-YiC, MeiZY, DeLongN, BrennerG, TaiM, DongW, DeLongGR. 2002. Effects of iodine supplementation during pregnancy on child growth and development at school age. Dev Med Child Neurol, 44:76–81.
149.
Fierro-BenitezR, CazarR, StanburyJB, RodriguezP, GarcesF, Fierro-RenoyF, EstrellaE. 1988. Effects on school children of prophylaxis of mothers with iodized oil in an area of iodine deficiency. J Endocrinol Invest, 11:327–335.
150.
CaoXY, JiangXM, DouZH, RakemanMA, ZhangML, O'DonnellK, MaT, AmetteK, DeLongN, DeLongGR. 1994. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med, 331:1739–1744.
151.
DeLongGR, LesliePW, WangSH, JiangXM, ZhangML, RakemanM, JiangJY, MaT, CaoXY. 1997. Effect on infant mortality of iodination of irrigation water in a severely iodine-deficient area of China. Lancet, 350:771–773.
152.
ChaoukiML, BenmiloudM. 1994. Prevention of iodine deficiency disorders by oral administration of lipiodol during pregnancy. Eur J Endocrinol, 130:547–551.
153.
AntonangeliL, MaccheriniD, CavaliereR, Di GiulioC, ReinhardtB, PincheraA, Aghini-LombardiF. 2002. Comparison of two different doses of iodide in the prevention of gestational goiter in marginal iodine deficiency: a longitudinal study. Eur J Endocrinol, 147:29–34.
154.
BerbelP, MestreJL, SantamariaA, PalazonI, FrancoA, GraellsM, Gonzalez-TorgaA, de EscobarGM. 2009. Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation. Thyroid, 19:511–519.
155.
GlinoerD, De NayerP, DelangeF, LemoneM, ToppetV, SpehlM, GrunJP, KinthaertJ, LejeuneB. 1995. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal, neonatal effects. J Clin Endocrinol Metab, 80:258–269.
156.
LiesenkotterKP, GopelW, BognerU, StachB, GrutersA. 1996. Earliest prevention of endemic goiter by iodine supplementation during pregnancy. Eur J Endocrinol, 134:443–448.
157.
NohrSB, LaurbergP. 2000. Opposite variations in maternal and neonatal thyroid function induced by iodine supplementation during pregnancy. J Clin Endocrinol Metab, 85:623–627.
158.
PedersenKM, LaurbergP, IversenE, KnudsenPR, GregersenHE, RasmussenOS, LarsenKR, EriksenGM, JohannesenPL. 1993. Amelioration of some pregnancy-associated variations in thyroid function by iodine supplementation. J Clin Endocrinol Metab, 77:1078–1083.
159.
RomanoR, JanniniEA, PepeM, GrimaldiA, OlivieriM, SpennatiP, CappaF, D'ArmientoM. 1991. The effects of iodoprophylaxis on thyroid size during pregnancy. Am J Obstet Gynecol, 164:482–485.
160.
VelascoI, CarreiraM, SantiagoP, MuelaJA, Garcia-FuentesE, Sanchez-MunozB, GarrigaMJ, Gonzalez-FernandezMC, RodriguezA, CaballeroFF, MachadoA, Gonzalez-RomeroS, AnarteMT, SoriguerF. 2009. Effect of iodine prophylaxis during pregnancy on neurocognitive development of children during the first two years of life. J Clin Endocrinol Metab, 94:3234–3241.
161.
TrumboP, YatesAA, SchlickerS, PoosM. 2001. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc, 101:294–301.
162.
U.S. Salt Institute. 2007. Iodized salt. www.saltinstitute.org/Uses-benefits/Salt-in-Food/Essential-nutrient/Iodized-salt. 2011 September 12.
ConradLM3rd, HemkenRW. 1978. Milk iodine as influenced by an iodophor teat dip. J Dairy Sci, 61:776–780.
165.
PearceEN, PinoS, HeX, BazrafshanHR, LeeSL, BravermanLE. 2004. Sources of dietary iodine: bread, cows' milk, and infant formula in the Boston area. J Clin Endocrinol Metab, 89:3421–3424.
Public Health Committee of the American Thyroid Association. BeckerDV, BravermanLE, DelangeF, DunnJT, FranklynJA, HollowellJG, LammSH, MitchellML, PearceE, RobbinsJ, RovetJF. 2006. Iodine supplementation for pregnancy and lactation—United States and Canada: recommendations of the American Thyroid Association. Thyroid, 16:949–951.
168.
GregoryCO, SerdulaMK, SullivanKM. 2009. Use of supplements with and without iodine in women of childbearing age in the United States. Thyroid, 19:1019–1020.
169.
LeungAM, PearceEN, BravermanLE. 2009. Iodine content of prenatal multivitamins in the United States. N Engl J Med, 360:939–940.
170.
PenningtonJA. 1990. A review of iodine toxicity reports. J Am Diet Assoc, 90:1571–1581.
171.
WolffJ, ChaikoffIL. 1948. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem, 174:555–564.
172.
EllishNJ, SabodaK, O'ConnorJ, NascaPC, StanekEJ, BoyleC. 1996. A prospective study of early pregnancy loss. Hum Reprod, 11:406–412.
173.
FisherDA, KleinAH. 1981. Thyroid development and disorders of thyroid function in the newborn. N Engl J Med, 304:702–712.
174.
TheodoropoulosT, BravermanLE, VagenakisAG. 1979. Iodide-induced hypothyroidism: a potential hazard during perinatal life. Science, 205:502–503.
175.
FangMC, StaffordRS, RuskinJN, SingerDE. 2004. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med, 164:55–60.
176.
AibaM, NinomiyaJ, FuruyaK, AraiH, IshikawaH, AsaumiS, TakagiA, OhwadaS, MorishitaY. 1999. Induction of a critical elevation of povidone-iodine absorption in the treatment of a burn patient: report of a case. Surg Today, 29:157–159.
177.
WilcoxAJ, WeinbergCR, O'ConnorJF, BairdDD, SchlattererJP, CanfieldRE, ArmstrongEG, NisulaBC. 1988. Incidence of early loss of pregnancy. N Engl J Med, 319:189–194.
178.
TothB, JeschkeU, RogenhoferN, ScholzC, WurfelW, ThalerCJ, MakrigiannakisA. 2010. Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol, 85:25–32.
De VivoA, MancusoA, GiacobbeA, MoletiM, Maggio SavastaL, De DominiciR, PrioloAM, VermiglioF. 2010. Thyroid function in women found to have early pregnancy loss. Thyroid, 20:633–637.
181.
Stagnaro-GreenA, RomanSH, CobinRH, el-HarazyE, Alvarez-MarfanyM, DaviesTF. 1990. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA, 264:1422–1425.
182.
IijimaT, TadaH, HidakaY, MitsudaN, MurataY, AminoN. 1997. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol, 90:364–369.
183.
GlinoerD, SotoMF, BourdouxP, LejeuneB, DelangeF, LemoneM, KinthaertJ, RobijnC, GrunJP, de NayerP. 1991. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab, 73:421–427.
184.
Sieiro NettoL, Medina CoeliC, MicmacherE, Mamede Da CostaS, NazarL, GalvaoD, BuescuA, VaismanM. 2004. Influence of thyroid autoimmunity and maternal age on the risk of miscarriage. Am J Reprod Immunol, 52:312–316.
185.
BagisT, GokcelA, SaygiliES. 2001. Autoimmune thyroid disease in pregnancy and the postpartum period: relationship to spontaneous abortion. Thyroid, 11:1049–1053.
186.
SezerK, KamelN, UnluC, CelikHK. 2009. Impact of first trimester and postpartum period thyroid autoantibodies on abortus incidence in Turkish pregnant women. Gynecol Endocrinol, 25:387–391.
ImaizumiM, PritskerA, KitaM, AhmadL, UngerP, DaviesT. 2001. Pregnancy and murine thyroiditis: thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies. Endocrinology, 142:823–829.
189.
MatalonST, BlankM, LevyY, CarpHJ, AradA, BurekL, GrunebaumE, ShererY, OrnoyA, RefetoffS, WeissRE, RoseNR, ShoenfeldY. 2003. The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Hum Reprod, 18:1094–1099.
190.
LeeYL, NgHP, LauKS, LiuWM, OWS, YeungWS, KungAW. 2009. Increased fetal abortion rate in autoimmune thyroid disease is related to circulating TPO autoantibodies in an autoimmune thyroiditis animal model. Fertil Steril, 91:2104–2109.
IravaniAT, SaeediMM, PakraveshJ, HamidiS, AbbasiM. 2008. Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study. Endocr Pract, 14:458–464.
194.
KuttehWH, YetmanDL, CarrAC, BeckLA, ScottRTJr. 1999. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril, 71:843–848.
195.
EsplinMS, BranchDW, SilverR, Stagnaro-GreenA. 1998. Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol, 179:1583–1586.
196.
PrattDE, KaberleinG, DudkiewiczA, KarandeV, GleicherN. 1993. The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester abortions in the next pregnancy. Fertil Steril, 60:1001–1005.
197.
RushworthFH, BackosM, RaiR, ChilcottIT, BaxterN, ReganL. 2000. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod, 15:1637–1639.
198.
De CarolisC, GrecoE, GuarinoMD, PerriconeC, Dal LagoA, GiacomelliR, FontanaL, PerriconeR. 2004. Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters. Am J Reprod Immunol, 52:263–266.
199.
KiprovDD, NachtigallRD, WeaverRC, JacobsonA, MainEK, GarovoyMR. 1996. The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol, 36:228–234.
200.
StrickerRB, SteinleitnerA, BookoffCN, WecksteinLN, WingerEE. 2000. Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin. Fertil Steril, 73:536–540.
201.
VaqueroE, LazzarinN, De CarolisC, ValensiseH, MorettiC, RamaniniC. 2000. Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach. Am J Reprod Immunol, 43:204–208.
202.
PoppeK, GlinoerD, TournayeH, DevroeyP, van SteirteghemA, KaufmanL, VelkeniersB. 2003. Assisted reproduction and thyroid autoimmunity: an unfortunate combination?J Clin Endocrinol Metab, 88:4149–4152.
203.
BussenS, SteckT, DietlJ. 2000. Increased prevalence of thyroid antibodies in euthyroid women with a history of recurrent in-vitro fertilization failure. Hum Reprod, 15:545–548.
204.
KimCH, ChaeHD, KangBM, ChangYS. 1998. Influence of antithyroid antibodies in euthyroid women on in vitro fertilization-embryo transfer outcome. Am J Reprod Immunol, 40:2–8.
205.
NegroR, FormosoG, CoppolaL, PresicceG, MangieriT, PezzarossaA, DazziD. 2007. Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function. J Endocrinol Invest, 30:3–8.
206.
KilicS, TasdemirN, YilmazN, YukselB, GulA, BatiogluS. 2008. The effect of anti-thyroid antibodies on endometrial volume, embryo grade and IVF outcome. Gynecol Endocrinol, 24:649–655.
207.
ToulisKA, GoulisDG, VenetisCA, KolibianakisEM, NegroR, TarlatzisBC, PapadimasI. 2010. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. Eur J Endocrinol, 162:643–652.
208.
NegroR, MangieriT, CoppolaL, PresicceG, CasavolaEC, GismondiR, LocorotondoG, CaroliP, PezzarossaA, DazziD, HassanH. 2005. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod, 20:1529–1533.
209.
MartinJA, OstermanMJ, SuttonPD. 2010. Are preterm births on the decline in the United States? Recent data from the National Vital Statistics System. NCHS Data Brief, 39:1–8.
210.
MathewsTJ, MenackerF, MacDormanMF. Centers for Disease Control Prevention, National Center for Health Statistics. 2004. Infant mortality statistics from the 2002 period: linked birth/infant death data set. Natl Vital Stat Rep, 53:1–29.
211.
PetrouS. 2005. The economic consequences of preterm birth during the first 10 years of life. BJOG, 112,Suppl 1:10–15.
212.
GoldenbergRL, CulhaneJF, IamsJD, RomeroR. 2008. Epidemiology and causes of preterm birth. Lancet, 371:75–84.
213.
LuewanS, ChakkabutP, TongsongT. 2010. Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet, 283:243.
214.
TietgensST, LeinungMC. 1995. Thyroid storm. Med Clin North Am, 79:169–184.
215.
GhafoorF, MansoorM, MalikT, MalikMS, KhanAU, EdwardsR, AkhtarW. 2006. Role of thyroid peroxidase antibodies in the outcome of pregnancy. J Coll Physicians Surg Pak, 16:468–471.
216.
HaddowJE, Cleary-GoldmanJ, McClainMR, PalomakiGE, NeveuxLM, Lambert-MesserlianG, CanickJA, MaloneFD, PorterTF, NybergDA, BernsteinPS, D'AltonME. First- and Second-Trimester Risk of Aneuploidy (FaSTER) Research Consortium. 2010. Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery. Obstet Gynecol, 116:58–62.
217.
StruveCW, HauptS, OhlenS. 1993. Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid, 3:7–9.
218.
KungAW, ChauMT, LaoTT, TamSC, LowLC. 2002. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab, 87:1010–1014.
219.
TanGH, GharibH, GoellnerJR, van HeerdenJA, BahnRS. 1996. Management of thyroid nodules in pregnancy. Arch Intern Med, 156:2317–2320.
220.
MarleyEF, OertelYC. 1997. Fine-needle aspiration of thyroid lesions in 57 pregnant and postpartum women. Diagn Cytopathol, 16:122–125.
SmithLH, DanielsenB, AllenME, CressR. 2003. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol, 189:1128–1135.
223.
LohKC. 1997. Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid, 7:107–113.
224.
HegedusL. 2004. Clinical practice. The thyroid nodule. N Engl J Med, 351:1764–1771.
225.
TuckerMA, JonesPH, BoiceJDJr, RobisonLL, StoneBJ, StovallM, JenkinRD, LubinJH, BaumES, SiegelSE. 1991. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res, 51:2885–2888.
226.
TanGH, GharibH, ReadingCC. 1995. Solitary thyroid nodule. Comparison between palpation and ultrasonography. Arch Intern Med, 155:2418–2423.
227.
GharibH, PapiniE, ValcaviR, BaskinHJ, CrescenziA, DottoriniME, DuickDS, GuglielmiR, HamiltonCRJr, ZeigerMA, ZiniM. AACE/AME Task Force on Thyroid Nodules. 2006. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract, 12:63–102.
228.
BranderA, ViikinkoskiP, TuuheaJ, VoutilainenL, KivisaariL. 1992. Clinical versus ultrasound examination of the thyroid gland in common clinical practice. J Clin Ultrasound, 20:37–42.
229.
PapiniE, GuglielmiR, BianchiniA, CrescenziA, TaccognaS, NardiF, PanunziC, RinaldiR, ToscanoV, PacellaCM. 2002. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab, 87:1941–1946.
230.
BennedbaekFN, PerrildH, HegedusL. 1999. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol (Oxf), 50:357–363.
231.
BennedbaekFN, HegedusL. 2000. Management of the solitary thyroid nodule: results of a North American survey. J Clin Endocrinol Metab, 85:2493–2498.
232.
HegedusL, BonnemaSJ, BennedbaekFN. 2003. Management of simple nodular goiter: current status and future perspectives. Endocr Rev, 24:102–132.
233.
CostanteG, MeringoloD, DuranteC, BianchiD, NoceraM, TuminoS, CrocettiU, AttardM, MaranghiM, TorlontanoM, FilettiS. 2007. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab, 92:450–455.
234.
BelfioreA, La RosaGL. 2001. Fine-needle aspiration biopsy of the thyroid. Endocrinol Metab Clin North Am, 30:361–400.
235.
GoellnerJR, GharibH, GrantCS, JohnsonDA. 1987. Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol, 31:587–590.
236.
AtkinsonBF. 1993. Fine needle aspiration of the thyroid. Monogr Pathol, 35:166–199.
237.
SolomonD. 1993. Fine needle aspiration of the thyroid: an update. Thyroid Today, 16:1–9.
238.
OertelYC. 1996. Fine-needle aspiration and the diagnosis of thyroid cancer. Endocrinol Metab Clin North Am, 25:69–91.
239.
SingerPA. 1996. Evaluation and management of the solitary thyroid nodule. Otolaryngol Clin North Am, 29:577–591.
240.
PowersCN, FrableWJ. 1996. Fine Needle Aspiration Biopsy of the Head and Neck. Butterworth-Heinemann: Boston.
241.
ChoeW, McDougallIR. 1994. Thyroid cancer in pregnant women: diagnostic and therapeutic management. Thyroid, 4:433–435.
242.
HamburgerJI. 1992. Thyroid nodules in pregnancy. Thyroid, 2:165–168.
243.
PauwelsEK, ThomsonWH, BloklandJA, SchmidtME, BourguignonM, El-MaghrabyTA, BroerseJJ, HardingLK. 1999. Aspects of fetal thyroid dose following iodine-131 administration during early stages of pregnancy in patients suffering from benign thyroid disorders. Eur J Nucl Med, 26:1453–1457.
244.
BergGE, NystromEH, JacobssonL, LindbergS, LindstedtRG, MattssonS, NiklassonCA, NorenAH, WestphalOG. 1998. Radioiodine treatment of hyperthyroidism in a pregnant women. J Nucl Med, 39:357–361.
245.
ZanzonicoPB. 1997. Radiation dose to patients and relatives incident to 131I therapy. Thyroid, 7:199–204.
246.
HerzonFS, MorrisDM, SegalMN, RauchG, ParnellT. 1994. Coexistent thyroid cancer and pregnancy. Arch Otolaryngol Head Neck Surg, 120:1191–1193.
247.
MoosaM, MazzaferriEL. 1997. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab, 82:2862–2866.
248.
ViniL, HyerS, PrattB, HarmerC. 1999. Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis. Postgrad Med J, 75:169–170.
249.
Monroy-LozanoBE, Hurtado-LopezLM, Zaldivar-RamirezFR, Basurto-KubaE. 2001. Clinical behavior of thyroid papillary cancer in pregnancy: optimal time for its treatment. Ginecol Obstet Mex, 69:359–362.
250.
YasmeenS, CressR, RomanoPS, XingG, Berger-ChenS, DanielsenB, SmithLH. 2005. Thyroid cancer in pregnancy. Int J Gynaecol Obstet, 91:15–20.
251.
NamKH, YoonJH, ChangHS, ParkCS. 2005. Optimal timing of surgery in well-differentiated thyroid carcinoma detected during pregnancy. J Surg Oncol, 91:199–203.
252.
VannucchiG, PerrinoM, RossiS, ColomboC, VicentiniL, DazziD, Beck-PeccozP, FugazzolaL. 2010. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol, 162:145–151.
253.
RosenIB, WalfishPG. 1986. Pregnancy as a predisposing factor in thyroid neoplasia. Arch Surg, 121:1287–1290.
254.
DohertyCM, ShindoML, RiceDH, MonteroM, MestmanJH. 1995. Management of thyroid nodules during pregnancy. Laryngoscope, 105:251–255.
255.
ChongKM, TsaiYL, ChuangJ, HwangJL, ChenKT. 2007. Thyroid cancer in pregnancy: a report of 3 cases. J Reprod Med, 52:416–418.
256.
KuyS, RomanSA, DesaiR, SosaJA. 2009. Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg, 144:399–406discussion 406.
257.
MestmanJH, GoodwinTM, MontoroMM. 1995. Thyroid disorders of pregnancy. Endocrinol Metab Clin North Am, 24:41–71.
258.
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. CooperDS, DohertyGM, HaugenBR, KloosRT, LeeSL, MandelSJ, MazzaferriEL, McIverB, PaciniF, SchlumbergerM, ShermanSI, StewardDL, TuttleRM. 2009. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19:1167–1214.
259.
PaciniF, SchlumbergerM, DralleH, EliseiR, SmitJW, WiersingaW. European Thyroid Cancer Taskforce. 2006. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol, 154:787–803.
260.
SawkaAM, LakraDC, LeaJ, AlshehriB, TsangRW, BrierleyJD, StrausS, ThabaneL, GafniA, EzzatS, GeorgeSR, GoldsteinDP. 2008. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function, future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf), 69:479–490.
261.
GarsiJP, SchlumbergerM, RubinoC, RicardM, LabbeM, CeccarelliC, SchvartzC, Henri-AmarM, BardetS, de VathaireF. 2008. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies. J Nucl Med, 49:845–852.
HillCSJr, ClarkRL, WolfM. 1966. The effect of subsequent pregnancy on patients with thyroid carcinoma. Surg Gynecol Obstet, 122:1219–1222.
264.
LeboeufR, EmerickLE, MartorellaAJ, TuttleRM. 2007. Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors. Thyroid, 17:543–547.
265.
RosarioPW, BarrosoAL, PurischS. 2007. The effect of subsequent pregnancy on patients with thyroid carcinoma apparently free of the disease. Thyroid, 17:1175–1176.
266.
HirschD, LevyS, TsvetovG, WeinsteinR, LifshitzA, SingerJ, Shraga-SlutzkyI, Grozinski-GlasbergS, ShimonI, BenbassatC. 2010. Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid, 20:1179–1185.
267.
AminoN, MoriH, IwataniY, TanizawaO, KawashimaM, TsugeI, IbaragiK, KumaharaY, MiyaiK. 1982. High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N Engl J Med, 306:849–852.
Stagnaro-GreenA, SchwartzA, GismondiR, TinelliA, MangieriT, NegroR. 2011. High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy. J Clin Endocrinol Metab, 96:652–657.
270.
MullerAF, DrexhageHA, BerghoutA. 2001. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev, 22:605–630.
271.
KuijpensJL, De Hann-MeulmanM, VaderHL, PopVJ, WiersingaWM, DrexhageHA. 1998. Cell-mediated immunity and postpartum thyroid dysfunction: a possibility for the prediction of disease?J Clin Endocrinol Metab, 83:1959–1966.
272.
Stagnaro-GreenA, RomanSH, CobinRH, el-HarazyE, WallensteinS, DaviesTF. 1992. A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab, 74:645–653.
273.
SmallridgeRC. 2000. Postpartum thyroid disease: a model of immunologic dysfunction. Clin Appl Immunol Rev, 1:89–103.
274.
AdamsH, JonesMC, OthmanS, LazarusJH, ParkesAB, HallR, PhillipsDI, RichardsCJ. 1992. The sonographic appearances in postpartum thyroiditis. Clin Radiol, 45:311–315.
275.
NicholsonWK, RobinsonKA, SmallridgeRC, LadensonPW, PoweNR. 2006. Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid, 16:573–582.
276.
GersteinHC. 1993. Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus. Ann Intern Med, 118:419–423.
277.
Alvarez-MarfanyM, RomanSH, DrexlerAJ, RobertsonC, Stagnaro-GreenA. 1994. Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab, 79:10–16.
278.
ElefsiniotisIS, VezaliE, PantazisKD, SaroglouG. 2008. Post-partum thyroiditis in women with chronic viral hepatitis. J Clin Virol, 41:318–319.
279.
Stagnaro-GreenA, AkhterE, YimC, DaviesTF, MagderL, PetriM. 2011. Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery. Lupus, 20:690.
280.
TagamiT, HagiwaraH, KimuraT, UsuiT, ShimatsuA, NaruseM. 2007. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease. Thyroid, 17:767–772.
281.
LazarusJH, AmmariF, OrettiR, ParkesAB, RichardsCJ, HarrisB. 1997. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract, 47:305–308.
282.
CaixasA, AlbaredaM, Garcia-PattersonA, Rodriguez-EspinosaJ, de LeivaA, CorcoyR. 1999. Postpartum thyroiditis in women with hypothyroidism antedating pregnancy?J Clin Endocrinol Metab, 84:4000–4005.
WalfishPG, MeyersonJ, ProviasJP, VargasMT, PapsinFR. 1992. Prevalence and characteristics of post-partum thyroid dysfunction: results of a survey from Toronto, Canada. J Endocrinol Invest, 15:265–272.
285.
HayslipCC, FeinHG, O'DonnellVM, FriedmanDS, KleinTA, SmallridgeRC. 1988. The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. Am J Obstet Gynecol, 159:203–209.
286.
LazarusJH. 1999. Clinical manifestations of postpartum thyroid disease. Thyroid, 9:685–689.
287.
PopVJ, de RooyHA, VaderHL, van der HeideD, van SonM, KomproeIH, EssedGG, de GeusCA. 1991. Postpartum thyroid dysfunction and depression in an unselected population. N Engl J Med, 324:1815–1816.
288.
LucasA, PizarroE, GranadaML, SalinasI, SanmartiA. 2001. Postpartum thyroid dysfunction and postpartum depression: are they two linked disorders?Clin Endocrinol (Oxf), 55:809–814.
289.
HarrisB, OthmanS, DaviesJA, WeppnerGJ, RichardsCJ, NewcombeRG, LazarusJH, ParkesAB, HallR, PhillipsDI. 1992. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ, 305:152–156.
290.
KuijpensJL, VaderHL, DrexhageHA, WiersingaWM, van SonMJ, PopVJ. 2001. Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. Eur J Endocrinol, 145:579–584.
291.
PopVJ, de RooyHA, VaderHL, van der HeideD, van SonMM, KomproeIH. 1993. Microsomal antibodies during gestation in relation to postpartum thyroid dysfunction and depression. Acta Endocrinol (Copenh), 129:26–30.
292.
HarrisB, OrettiR, LazarusJ, ParkesA, JohnR, RichardsC, NewcombeR, HallR. 2002. Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women. Br J Psychiatry, 180:327–330.
293.
TachiJ, AminoN, TamakiH, AozasaM, IwataniY, MiyaiK. 1988. Long term follow-up and HLA association in patients with postpartum hypothyroidism. J Clin Endocrinol Metab, 66:480–484.
294.
FungHY, KologluM, CollisonK, JohnR, RichardsCJ, HallR, McGregorAM. 1988. Postpartum thyroid dysfunction in Mid Glamorgan. Br Med J (Clin Res Ed), 296:241–244.
295.
VargasMT, Briones-UrbinaR, GladmanD, PapsinFR, WalfishPG. 1988. Antithyroid microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid dysfunction: evidence supporting an autoimmune pathogenesis. J Clin Endocrinol Metab, 67:327–333.
296.
RasmussenNG, HornnesPJ, Hoier-MadsenM, Feldt-RasmussenU, HegedusL. 1990. Thyroid size and function in healthy pregnant women with thyroid autoantibodies. Relation to development of postpartum thyroiditis. Acta Endocrinol (Copenh), 123:395–401.
297.
AziziF. 2005. The occurrence of permanent thyroid failure in patients with subclinical postpartum thyroiditis. Eur J Endocrinol, 153:367–371.
298.
NohrSB, JorgensenA, PedersenKM, LaurbergP. 2000. Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe?J Clin Endocrinol Metab, 85:3191–3198.
299.
KampeO, JanssonR, KarlssonFA. 1990. Effects of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab, 70:1014–1018.
300.
KleinRZ, HaddowJE, FaixJD, BrownRS, HermosRJ, PulkkinenA, MitchellML. 1991. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf), 35:41–46.
301.
PopVJ, KuijpensJL, van BaarAL, VerkerkG, van SonMM, de VijlderJJ, VulsmaT, WiersingaWM, DrexhageHA, VaderHL. 1999. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf), 50:149–155.
302.
LazarusJ. 2010. Outcome of the CATS study. Oral presentation at the International Thyroid Congress (ITC)Paris, France, September11–16Symposium no. 18.
303.
DosiouC, SandersGD, ArakiSS, CrapoLM. 2008. Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. Eur J Endocrinol, 158:841–851.
304.
ThungSF, FunaiEF, GrobmanWA. 2009. The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism. Am J Obstet Gynecol, 200:267.e1–267.e7.
305.
VaidyaB, AnthonyS, BilousM, ShieldsB, DruryJ, HutchisonS, BilousR. 2007. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding?J Clin Endocrinol Metab, 92:203–207.
306.
HoracekJ, SpitalnikovaS, DlabalovaB, MalirovaE, VizdaJ, SviliasI, CepkovaJ, Mc GrathC, MalyJ. 2010. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol, 163:645–650.
307.
De CarlucciDJr, TavaresMR, ObaraMT, MartinsLA, HojaijFC, CerneaCR. 2008. Thyroid function after unilateral total lobectomy: risk factors for postoperative hypothyroidism. Arch Otolaryngol Head Neck Surg, 134:1076–1079.
CanarisGJ, SteinerJF, RidgwayEC. 1997. Do traditional symptoms of hypothyroidism correlate with biochemical disease?J Gen Intern Med, 12:544–550.
310.
Jovanovic-PetersonL, PetersonCM. 1988. De novo clinical hypothyroidism in pregnancies complicated by type I diabetes, subclinical hypothyroidism, and proteinuria: a new syndrome. Am J Obstet Gynecol, 159:442–446.
311.
LadensonPW. 2005. Diagnosis of hypothyroidism. BravermanLE, UtigerRD. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 9th. Lippincott, Williams & Wilkins: Philadelphia, 857–863.
312.
PoppeK, GlinoerD, Van SteirteghemA, TournayeH, DevroeyP, SchiettecatteJ, VelkeniersB. 2002. Thyroid dysfunction and autoimmunity in infertile women. Thyroid, 12:997–1001.
313.
MercadoG, AdelsteinDJ, SaxtonJP, SecicM, LartoMA, LavertuP. 2001. Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer, 92:2892–2897.
314.
RotondiM, LeporatiP, La MannaA, PiraliB, MondelloT, FonteR, MagriF, ChiovatoL. 2009. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism?Eur J Endocrinol, 160:403–408.
315.
MichalakiMA, VagenakisAG, LeonardouAS, ArgentouMN, HabeosIG, MakriMG, PsyrogiannisAI, KalfarentzosFE, KyriazopoulouVE. 2006. Thyroid function in humans with morbid obesity. Thyroid, 16:73–78.
316.
HollowellJG, StaehlingNW, FlandersWD, HannonWH, GunterEW, SpencerCA, BravermanLE. 2002. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)J Clin Endocrinol Metab, 87:489–499.
317.
EskesSA, WiersingaWM. 2009. Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab, 23:735–751.
318.
LazarusJH. 2009. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab, 23:723–733.
319.
VagenakisAG, BravermanLE. 1975. Adverse effects of iodides on thyroid function. Med Clin North Am, 59:1075–1088.